Compare PASG & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PASG | FOFO |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | Hong Kong |
| Employees | 27 | 14 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0M | 29.7M |
| IPO Year | 2020 | N/A |
| Metric | PASG | FOFO |
|---|---|---|
| Price | $5.20 | $2.00 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 64.6K | 57.8K |
| Earning Date | 05-12-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $1.86 |
| 52 Week High | $20.00 | $68.00 |
| Indicator | PASG | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 42.65 | 26.93 |
| Support Level | $3.94 | N/A |
| Resistance Level | $5.74 | $5.74 |
| Average True Range (ATR) | 0.38 | 0.24 |
| MACD | 0.18 | 0.01 |
| Stochastic Oscillator | 69.53 | 12.68 |
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.